NCT02293265
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Fresno, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Newport Beach, California, United States